Heinz Gisslinger, MD, Medical University of Vienna, discusses differences between polycythemia vera (PV) and essential thrombocythemia (ET).
Heinz Gisslinger, MD
Advertisement
Articles by Heinz Gisslinger, MD
Heinz Gisslinger, MD, Medical University of Vienna, discusses new compounds in polycythemia vera (PV).
Advertisement
Latest Updated Articles
New Compounds in PVPublished: September 13th 2016 | Updated:
Differences Between Polycythemia Vera and Essential ThrombocythemiaPublished: September 29th 2016 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
